| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/25/2009 | CA2699496A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | CA2699480A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/24/2009 | EP2072060A1 Methods and compositions for the preparation and use of toxin conjugates. |
| 06/24/2009 | EP2072059A1 Use of bispecific antibodies to regulate immune responses |
| 06/24/2009 | EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 06/24/2009 | EP2072044A1 Pharmaceutical dosage form comprising a liquid or flowable core composition |
| 06/24/2009 | EP1706145B1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 06/24/2009 | EP1686959B1 Pharmaceutical formulations employing short-chain sphingolipids and their use |
| 06/24/2009 | EP1509243A4 Topical drug delivery using phosphatidylcholine |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1314436B1 Antiviral composition comprising interferon in the form of nose drops |
| 06/24/2009 | EP1131106B1 Compositions and methods for producing vascular occlusion |
| 06/24/2009 | EP1011733B1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 06/24/2009 | CN101466409A Leptomycin derivatives |
| 06/24/2009 | CN101466408A Polycation-polyanion complexes, compositions and methods of use thereof |
| 06/24/2009 | CN101466407A Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 06/24/2009 | CN101466357A Direct cellular energy delivery system |
| 06/24/2009 | CN101461949A Berberine cyclodextrin inclusion compound, preparation thereof and preparation method |
| 06/24/2009 | CN101461948A Acidum folicum mediated 5-efudix albumin macromolecule precursor medicament as well as preparation method and use thereof |
| 06/24/2009 | CN101461947A Polypeptide tree-shaped macromolecule as gene vector and use thereof |
| 06/24/2009 | CN101461946A Anti-tumor tree-shaped polypeptide macromolecule medicament carrier system |
| 06/24/2009 | CN101461945A Method for preparing alginic acid magnetic material |
| 06/24/2009 | CN101461944A Magnetic polyacrylic acid modified carbon nano-tube medicament carrier |
| 06/24/2009 | CN101461943A Micropore ceramics and method for sustained-release of medicament or biological preparation and use thereof |
| 06/24/2009 | CN100503797C Grease of fructus cannabis, preparation method and application |
| 06/24/2009 | CN100503435C Nano level active carbon and its preparation and use |
| 06/24/2009 | CN100502950C Modified natural polymer medical adjuvant, its preparation method and use |
| 06/24/2009 | CN100502949C Polymer coated particle of slow release |
| 06/24/2009 | CN100502948C Magnetic high polymer nanometer micro-balls type medicine carrying system, and its preparation method |
| 06/24/2009 | CN100502884C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/24/2009 | CN100502873C Formulations containing cephalosporin |
| 06/24/2009 | CN100502852C Flurbiprofenbab preparation and its preparation method |
| 06/24/2009 | CN100502839C Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 06/24/2009 | CN100502834C Amphotericin B structured emulsion |
| 06/23/2009 | US7550609 Biological conjugates for tumor targeted treatment; novel taxanes having mercapto or disulfide groups; side effect reduction without compromising their cytotoxicity |
| 06/23/2009 | US7550569 Antibodies that specifically bind to GMAD |
| 06/23/2009 | US7550566 G-CSF conjugates |
| 06/23/2009 | US7550565 G-CSF conjugates |
| 06/23/2009 | US7550512 Polyethylene glycol containing sugar residue and carboxylic acid side chains; drug delivery and gene transfer carrier; aggregation inhibition; expression efficiency; water solubility |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550445 Inclusion complex in a beta-cyclodextrin, preferably, sulfobutyl ether beta-cyclodextrin, in the form of an injectable material; reducing irritation normally caused by aripiprazole at an intramuscular injection site; for treating schizophrenia |
| 06/23/2009 | US7550444 Coatings with heparin activity, some able to release a bioactive agent; coatings can be formed using biostable or biodegradable polymeric material and photoreactive groups; improving the quality of bioactive agent-containing coatings by performing pre-irradiation of biocompatible coatings |
| 06/23/2009 | US7550441 Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting |
| 06/23/2009 | US7550434 preparing a sealed vial or sealed cartridge for storage stability, resist to oxidation and chemical; including BUFFER AND A POLYOL; MANNITOL, BUFFER OF AN ACETATE OR TARTRATE, M-CRESOL OR BENZYL ALCOHOL PRESERVATIVE; parathyroid hormone for treating osteoporosis |
| 06/23/2009 | US7550428 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 06/23/2009 | US7550282 Biological glue based on thrombin-conjugated nanoparticles |
| 06/23/2009 | US7550272 Method for diagnosis of pancreatic exocrine function |
| 06/23/2009 | US7550157 Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 06/23/2009 | US7550156 For pharmaceutical, agrochemical, water treatment, water softening, fabric softening or detergent compositions; cross-linked polyacrylate water absorbent disintegration agent; starch or derivative water transport agent |
| 06/23/2009 | US7550155 two excipients are: a block co-polymer (for example, a poloxamer ), and a polyethylene glycol (PEG); with this synergistic mixture it is possible to dissolve or suspend higher amounts of propofol and other lipophilic compounds while, at the same time, using smaller amounts of these excipients |
| 06/23/2009 | US7550153 Pantoprazole multiparticulate formulations |
| 06/23/2009 | US7550145 Adjuvant compositions |
| 06/23/2009 | US7550141 Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids |
| 06/23/2009 | CA2521509C Fast dissolving orally consumable films containing pharmaceutically active agents |
| 06/23/2009 | CA2459483C Plaster for the treatment of dysfunctions and disorders of nail growth |
| 06/23/2009 | CA2459400C Plaster for the treatment of dysfunctions and disorders of nails |
| 06/23/2009 | CA2405046C Stabilized pharmaceutical compositions comprising a calcium blocker and an alkaline material |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
| 06/23/2009 | CA2373611C Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
| 06/23/2009 | CA2370023C Transdermal therapeutic system with a highly effective neuroleptic agent |
| 06/23/2009 | CA2367387C Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| 06/23/2009 | CA2362728C Improved aqueous solubility pharmaceutical formulations |
| 06/23/2009 | CA2355932C Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| 06/23/2009 | CA2304820C Stabilized bioactive preparations and methods of use |
| 06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/18/2009 | WO2009075859A2 Formulation of insulinotropic peptide conjugates |
| 06/18/2009 | WO2009075383A1 Skin external preparation and method of producing the same |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075329A1 Gelatin composition with controlled degradability |
| 06/18/2009 | WO2009075324A1 Loxoprofen-containing aqueous plaster |
| 06/18/2009 | WO2009075309A1 Preparation composition |
| 06/18/2009 | WO2009075258A1 Transdermally absorptive preparation |
| 06/18/2009 | WO2009075142A1 Bactericidal cleanser composition |
| 06/18/2009 | WO2009075094A1 Tape preparation comprising etodolac in ionic liquid form |
| 06/18/2009 | WO2009074678A2 Anticancer conjugates of camptothecin to hyaluronic acid |
| 06/18/2009 | WO2009074569A1 Targeting and therapeutic compounds with a polyproline-comprising spacer and gas-filled microvesicles comprising said compounds |
| 06/18/2009 | WO2009074336A1 Quarternization of the additive amino alkyl methacrylate copolymer e for improving permeability and solubility of pharmaceuticals |
| 06/18/2009 | WO2009074239A1 Pharmaceutical foams |
| 06/18/2009 | WO2009073984A1 High-density lipoprotein-like peptide-phospholipid scaffold ('hpps') nanoparticles |
| 06/18/2009 | WO2009073940A2 Use of phthalimide derivatives in the treatment of diseases |
| 06/18/2009 | WO2009010296A3 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof |
| 06/18/2009 | WO2008152444A3 Foamable waterless compositions with modulating agents |
| 06/18/2009 | WO2008141107A8 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 06/18/2009 | WO2008135601A3 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation |
| 06/18/2009 | WO2008089709A3 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 06/18/2009 | WO2008083370A3 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid |
| 06/18/2009 | WO2004017754A3 Food supplements from freeze-dried bovine tissues & method of ordering food supplements |
| 06/18/2009 | WO2003089458A3 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 06/18/2009 | US20090158462 Method for Producing Polyunsaturated C20 and C22 Fatty Acids with at Least Four Double Bonds in Transgenic Plants |
| 06/18/2009 | US20090157017 Bioresorbable foaming tissue dressing |
| 06/18/2009 | US20090156790 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 06/18/2009 | US20090156742 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 06/18/2009 | US20090156694 Long-chain polyunsaturated fatty acid oil and compositions and preparation process for the same |
| 06/18/2009 | US20090156693 Ophthalmic compositions containing polysaccharide/borate gelling system |
| 06/18/2009 | US20090156692 Use of oligomers and polymers for drug solubilization, stabilization, and delivery |
| 06/18/2009 | US20090156691 Cell culture carrier implantable in vivo |
| 06/18/2009 | US20090156677 Gabapentin-containing Solid Compositions and Process for Preparing the Same |
| 06/18/2009 | US20090156629 Indenoisoquinoline-releasable polymer conjugates |